MAZZUCCHI, SONIA
 Distribuzione geografica
Continente #
NA - Nord America 1.540
EU - Europa 798
AS - Asia 299
AF - Africa 66
OC - Oceania 4
SA - Sud America 2
Totale 2.709
Nazione #
US - Stati Uniti d'America 1.515
IT - Italia 268
SE - Svezia 212
CN - Cina 136
DE - Germania 115
SG - Singapore 106
BG - Bulgaria 66
AT - Austria 44
CI - Costa d'Avorio 41
GB - Regno Unito 31
VN - Vietnam 25
CA - Canada 22
SN - Senegal 17
TR - Turchia 17
FI - Finlandia 13
FR - Francia 8
IE - Irlanda 7
IN - India 7
NL - Olanda 7
RU - Federazione Russa 7
NG - Nigeria 6
BE - Belgio 5
HK - Hong Kong 5
PL - Polonia 5
AU - Australia 4
CZ - Repubblica Ceca 3
ES - Italia 2
IR - Iran 2
MA - Marocco 2
MX - Messico 2
AR - Argentina 1
BR - Brasile 1
BY - Bielorussia 1
DO - Repubblica Dominicana 1
EE - Estonia 1
IM - Isola di Man 1
JP - Giappone 1
LT - Lituania 1
NO - Norvegia 1
Totale 2.709
Città #
Woodbridge 196
Fairfield 168
Chandler 139
Ann Arbor 103
Ashburn 86
Houston 84
Seattle 84
Wilmington 69
Sofia 66
New York 64
Cambridge 56
Milan 56
Santa Clara 54
Singapore 52
Serra 42
Vienna 42
Abidjan 41
Florence 39
Frankfurt am Main 39
Boardman 35
Princeton 35
Lawrence 30
Medford 29
Beijing 28
Pisa 26
Guangzhou 23
Trieste 23
Bremen 21
Ottawa 19
Des Moines 18
Dakar 17
Istanbul 16
Ogden 14
Dong Ket 11
Dearborn 10
San Diego 10
Los Angeles 9
Fuzhou 8
Nanjing 8
Quanzhou 8
Shanghai 8
Lagos 6
London 6
Massa E Cozzile 6
Norwalk 6
Nürnberg 6
Brussels 5
Redwood City 5
Warsaw 5
Falls Church 4
Galway 4
Helsinki 4
Hong Kong 4
Lancaster 4
Vecchiano 4
Vicopisano 4
Brno 3
Indiana 3
Moscow 3
Paris 3
Rho 3
Agadir 2
Amsterdam 2
Barcelona 2
Burlington 2
Calgary 2
Canosa Di Puglia 2
Changsha 2
Chicago 2
Cuauhtémoc 2
Hangzhou 2
Harbin 2
Hebei 2
Hefei 2
Kostroma 2
Manchester 2
Massarosa 2
Maynooth 2
Medolago 2
Munich 2
Nanchang 2
Pune 2
Rome 2
Rourkela 2
Shenyang 2
Southwark 2
Tianjin 2
Utrecht 2
Wuhan 2
Xian 2
Acton 1
Ames 1
Baotou 1
Bergen 1
Boston 1
Boydton 1
Brescia 1
Buenos Aires 1
Böblingen 1
Canberra 1
Totale 2.042
Nome #
Chronic Migraine with Medication Overuse and OnabotulinumtoxinA: Two Positive Case Reports of a Modified Injection Protocol 151
Mild affective symptoms in de novo Parkinson's disease patients: relationship with dopaminergic dysfunction 148
Social Cognition and Oxytocin in Huntington’s Disease: New Insights 137
Efficacy of a combined therapeutic approach in the management of Pisa Syndrome 126
The relationship between motor symptom lateralization and cognitive performance in newly diagnosed drug-na?ve patients with Parkinson's disease. 121
Current treatment and future prospects of dopa-induced dyskinesias. 118
Antipsychotic drugs in Huntington's disease 118
Migraine features in migraineurs with and without anxiety-depression symptoms: A hospital-based study 117
Serotonergic antidepressant drugs and L-dopa-induced dyskinesias in Parkinson's disease. 112
Brain-Derived Neurotrophic Factor (BDNF) and Serotonin Transporter (SERT) in Platelets of Patients with Mild Huntington’s Disease: Relationships with Social Cognition Symptoms 111
Different Clinical Contexts of Use of Blood Neurofilament Light Chain Protein in the Spectrum of Neurodegenerative Diseases 100
Postural Abnormalities in Parkinson's Disease: An Epidemiological and Clinical Multicenter Study 93
Symptomatic orthostatic tremor associated with Graves' disease. 92
null 86
Head tremor as a warning symptom of rapidly progressive syringomyelia: a case report 85
Which patients discontinue? Issues on Levodopa/carbidopa intestinal gel treatment: Italian multicentre survey of 905 patients with long-term follow-up 83
Bipolar Spectrum disorders in Parkinson's disease: a systematic evaluation 81
Plasma levels of oxidative stress markers, before and after BoNT/A Treatment, in chronic migraine 79
null 75
Automated MRI Classification in Progressive Supranuclear Palsy: a Large International Cohort Study 74
Quantitative susceptibility mapping in atypical Parkinsonisms 71
Connected speech in progressive supranuclear palsy: a possible role in differential diagnosis 67
Prevalence and clinical correlates of comorbid anxiety and panic disorders in patients with Parkinson’s disease 52
A New MRI Measure to Early Differentiate Progressive Supranuclear Palsy From De Novo Parkinson's Disease in Clinical Practice: An International Study 50
Cgrp inhibitors and oxidative stress biomarkers in resistant migraine: A real‐life study with erenumab, fremanezumab and galcanezumab 49
Does the Degree of Trunk Bending Predict Patient Disability, Motor Impairment, Falls, and Back Pain in Parkinson's Disease? 48
Supersaturation of VEP in Migraine without Aura Patients Treated with Topiramate: An Anatomo-Functional Biomarker of the Disease 48
Prevalence and impact of COVID-19 in Parkinson’s disease: evidence from a multi-center survey in Tuscany region 47
Neuroimaging in idiopathic adult-onset focal dystonia 43
Nigral involvement and nigrostriatal dysfunction in Huntington's disease: evidences from an MRI and SPECT study. 40
The role of synaptic biomarkers in the spectrum of neurodegenerative diseases 37
Functional gait disorders: Demographic and clinical correlations 36
Development and Validation of Automated Magnetic Resonance Parkinsonism Index 2.0 to Distinguish Progressive Supranuclear Palsy-Parkinsonism From Parkinson's Disease 21
Morphometric imaging and quantitative susceptibility mapping as complementary tools in the diagnosis of parkinsonisms 18
Data-driven clustering of combined Functional Motor Disorders based on the Italian registry 16
Perampanel as a novel treatment for subcortical myoclonus in myoclonus-dystonia syndrome 15
Tardive Syndrome Associated With Tetrabenazine in Huntington Disease: A Case Report 3
Totale 2.768
Categoria #
all - tutte 9.520
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.520


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020273 0 0 0 0 30 50 43 40 45 31 20 14
2020/2021273 11 44 7 16 12 10 65 16 21 18 13 40
2021/2022378 9 6 5 23 73 51 13 23 34 18 27 96
2022/2023606 81 88 53 38 52 64 8 31 121 0 59 11
2023/2024407 34 33 41 37 48 87 24 19 5 13 37 29
2024/2025227 13 40 34 78 62 0 0 0 0 0 0 0
Totale 2.768